Dr. Natarajan holds a Ph.D. from Nanyang Technological University (NTU) in Singapore and was previously the head of the R&D group at Evonik Vancouver Laboratories.
Jay is currently serving as the Director of Technical Business Development and Marketing for the Asia Pacific region and is based in Singapore.
He started his professional career with Sun Pharma and was instrumental in the commercial scale up of LipoDox.
Thereafter, he held various positions with different centers and institutes of NTU albeit his focus always revolved around the research and development of nanomedicines, particularly lipid nanoparticles.
Jay is the author of ten peer-reviewed papers and an inventor on two patents.